Topic

Articles

Pfizer and Gero have partnered to discover potential therapeutic targets for fibrotic diseases using machine learning technology.

Pfizer and Gero Form Collaboration to Discover Potential Targets for Fibrotic Diseases

The collaboration between AbbVie and Anima Biotech will combine Anima's mRNA Lightning technology platform with AbbVie's extensive expertise in oncology and immunology.

AbbVie and Anima Biotech Partner on Discovery and Development of mRNA Biology Modulators

GSK and Wave Life Sciences have entered into a collaboration to drive drug discovery and development for novel genetic targets.

GSK and Wave Life Sciences to Collaborate on Oligonucleotide Therapeutics

AbCellera and Rallybio are teaming up to discover, develop, and commercialize novel antibody-based therapeutics for rare diseases.

AbCellera and Rallybio Partner on Novel Antibody-Based Therapeutics

Synthego has launched new engineered cell libraries to validate targets for quicker drug discovery timelines.

Synthego Aims to Accelerate Drug Discovery with New Engineered Cell Libraries

Merck, known as MSD outside the United States and Canada, now offers the Merck Digital Sciences Studio, designed to enable innovative tech for drug discovery and development.

Merck Digital Sciences Studio Supports Early-Stage Startups

Feliza Mirasol is the science editor for 

Advances in genomics tools can lead to quicker biotherapeutic development.

Employing Genomics Tools to Accelerate Drug Development

Thermo Fisher and Symphogen have extended their collaboration involving improved data workflow, which supports the discovery and development of new cancer treatments.

Thermo Fisher Scientific Extends Collaboration Support for Biopharma Discovery and Development

GlaxoSmithKline, together with the University of Oxford, has launched the Oxford-GSK Institute under a new collaboration that aims to study complex diseases to accelerate the success of drug discovery and drug development efforts.

GSK and University of Oxford Partner on Disease Research to Advance Drug Discovery and Development

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.

Discovery Pipeline